{"log_id": 2354345067411856398, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.000927, "average": 0.989684, "min": 0.814997}, "location": {"width": 796, "top": 243, "height": 35, "left": 227}, "words": "本品不适用于内分泌状态为绝经前的女性。因此,如临床允许,应进行LH、FSH和二醇水平的"}, {"probability": {"variance": 0.007182, "average": 0.98322, "min": 0.44219}, "location": {"width": 793, "top": 270, "height": 33, "left": 227}, "words": "检测以确定是否处于绝经后状态。也不应与含有雌激素的药物联合使用,此类药物将影响其药理"}, {"probability": {"variance": 4e-06, "average": 0.99779, "min": 0.995711}, "location": {"width": 36, "top": 297, "height": 22, "left": 227}, "words": "作用"}, {"probability": {"variance": 0.000547, "average": 0.990024, "min": 0.911762}, "location": {"width": 303, "top": 346, "height": 23, "left": 228}, "words": "有肝功能或肾功能损害的患者应慎用"}, {"probability": {"variance": 0.003822, "average": 0.973682, "min": 0.726761}, "location": {"width": 809, "top": 393, "height": 27, "left": 224}, "words": "依西美坦片剂含有蔗糖,对于罕见糖耐量异常,葡萄糖-半乳糖吸收障碍或蔗糖酶-异麦芽糖酶不足"}, {"probability": {"variance": 5e-05, "average": 0.996288, "min": 0.97476}, "location": {"width": 268, "top": 418, "height": 24, "left": 225}, "words": "的遗传性疾病的患者,不应使用"}, {"probability": {"variance": 0.00237, "average": 0.987397, "min": 0.700984}, "location": {"width": 699, "top": 466, "height": 26, "left": 225}, "words": "依西美坦片剂含有甲基碎酸化羟基苯,该成份可引起过敏反应(可能表现为迟发性)"}, {"probability": {"variance": 0.000344, "average": 0.994585, "min": 0.881671}, "location": {"width": 810, "top": 514, "height": 23, "left": 225}, "words": "由于本品是强效降低激素的药物,治疗后已观察到骨密度降低和增加的骨折率(见【临床试"}, {"probability": {"variance": 0, "average": 0.996576, "min": 0.996576}, "location": {"width": 19, "top": 542, "height": 18, "left": 225}, "words": "验"}, {"probability": {"variance": 5.3e-05, "average": 0.996738, "min": 0.963218}, "location": {"width": 732, "top": 538, "height": 25, "left": 304}, "words": "依西美坦用于辅助治疗时,患有骨质疏松症或有骨质疏松风险的女性在治疗开始时应采"}, {"probability": {"variance": 0.002266, "average": 0.989612, "min": 0.689992}, "location": {"width": 793, "top": 561, "height": 26, "left": 224}, "words": "用骨密度测量法对骨矿物质密度进行正规检查。尽管尚无足够数据表明本品会引起骨密度降低"}, {"probability": {"variance": 8.8e-05, "average": 0.995478, "min": 0.95708}, "location": {"width": 627, "top": 589, "height": 23, "left": 225}, "words": "但如需要则应进行骨质疏松的治疗。接受本品治疗的患者应仔细监测骨密度"}, {"probability": {"variance": 0.008292, "average": 0.969257, "min": 0.513512}, "location": {"width": 810, "top": 635, "height": 25, "left": 225}, "words": "因为早期乳腺癌妇女中相关的维生素D严重缺乏极其普遍,应该在开始芳香酶抑制剂治疗前考虑进"}, {"probability": {"variance": 6.6e-05, "average": 0.994459, "min": 0.968166}, "location": {"width": 280, "top": 663, "height": 21, "left": 226}, "words": "行25羟基维生素D水平的例行评估"}, {"probability": {"variance": 1.2e-05, "average": 0.997881, "min": 0.987097}, "location": {"width": 217, "top": 710, "height": 22, "left": 231}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.000952, "average": 0.982543, "min": 0.919948}, "location": {"width": 152, "top": 736, "height": 22, "left": 228}, "words": "孕妇:妊娠分类X。"}, {"probability": {"variance": 0.0037, "average": 0.981895, "min": 0.622191}, "location": {"width": 800, "top": 779, "height": 27, "left": 227}, "words": "妊娠妇女应用依西美坦可能有胎毒性,且对绝经前乳腺癌妇女未证实临床获益。依西美坦禁用于"}, {"probability": {"variance": 0.000459, "average": 0.988737, "min": 0.88722}, "location": {"width": 664, "top": 805, "height": 27, "left": 228}, "words": "妊娠或可能妊娠的妇女。依西美坦没有在妊娠妇女中进行足够且控制良好的研究"}, {"probability": {"variance": 0.007648, "average": 0.964729, "min": 0.515092}, "location": {"width": 806, "top": 849, "height": 30, "left": 227}, "words": "给大鼠口服1mg/kg的依丙美坦,发现C标记的依西美坦能透过胎盘。母鼠和胚胎血液内依西美"}, {"probability": {"variance": 0.015143, "average": 0.960954, "min": 0.350791}, "location": {"width": 812, "top": 874, "height": 28, "left": 229}, "words": "坦及其代谢产物的浓度大致相等,在交配前14天起给大鼠口饲依西美坦到妊娠的第15或20天"}, {"probability": {"variance": 0.015594, "average": 0.943572, "min": 0.45512}, "location": {"width": 797, "top": 899, "height": 29, "left": 227}, "words": "然后在唯乳期第21天起重新绘予依西美坦,当依西美的剂量达到4mg/kg天(约桶当于人用推"}, {"probability": {"variance": 0.010885, "average": 0.944157, "min": 0.580194}, "location": {"width": 765, "top": 924, "height": 28, "left": 228}, "words": "荐剂量的1.5倍,按mg/m2计算)时可以观察到胎盘重量的增加。当依西美坦剂盘等于或大于"}, {"probability": {"variance": 0.009118, "average": 0.963437, "min": 0.51198}, "location": {"width": 772, "top": 948, "height": 31, "left": 230}, "words": "2mg/kg天时可以观察到过期妊娠和异常分娩或难产。在这些剂量也可以观察到胚胎吸收加"}, {"probability": {"variance": 0.01046, "average": 0.967304, "min": 0.540517}, "location": {"width": 800, "top": 973, "height": 31, "left": 228}, "words": "存活胎仔数量下降、胎仔体重下降和骨化延迟。在胎仔器官发生阶段给予妊娠大鼠依西美坦,剂"}, {"probability": {"variance": 0.003845, "average": 0.978016, "min": 0.634816}, "location": {"width": 809, "top": 998, "height": 32, "left": 229}, "words": "量直至810mg/kg/天(约相当于人月推荐剂量的320倍,按mg/m2计算)也未观察到胎仔畸形。在"}, {"probability": {"variance": 0.01798, "average": 0.948007, "min": 0.394787}, "location": {"width": 800, "top": 1024, "height": 30, "left": 228}, "words": "胎仔器官发生阶段给予兔子每天削量的依西美坦,剂量在90mg/kg/天(约相当于人用荐剂量的"}, {"probability": {"variance": 0.007578, "average": 0.965173, "min": 0.477385}, "location": {"width": 795, "top": 1049, "height": 31, "left": 229}, "words": "70倍,按mg/m2计算)时可以导致治盘重量的下降。剂量在270mg/kg天时可以观察到流产、胚"}, {"probability": {"variance": 0.007744, "average": 0.947637, "min": 0.654213}, "location": {"width": 792, "top": 1074, "height": 32, "left": 229}, "words": "胎吸收潜加和胎仔体重下降。在兔子中剂量直至270gkg/天(约相当于人用推荐削量的210倍"}, {"probability": {"variance": 0.00944, "average": 0.950728, "min": 0.651989}, "location": {"width": 401, "top": 1100, "height": 31, "left": 229}, "words": "按mg/m2汁算)时未发现胎仔畸形发生率的增加"}, {"probability": {"variance": 0.010226, "average": 0.968547, "min": 0.429713}, "location": {"width": 815, "top": 1142, "height": 34, "left": 228}, "words": "如果患者在妊娠期间使用该药,或在使该药期发竺妊娠,应告知患者该药对胎儿的潜在危害"}, {"probability": {"variance": 0.00354, "average": 0.967428, "min": 0.826642}, "location": {"width": 149, "top": 1177, "height": 21, "left": 230}, "words": "及流产的潜在风险"}, {"probability": {"variance": 0.001147, "average": 0.986941, "min": 0.838586}, "location": {"width": 770, "top": 1213, "height": 35, "left": 231}, "words": "哺乳期妇女:本品仅适用于绝经后妇女。然而,大鼠口饲放射标记的依西美坦后15分钟内乳"}, {"probability": {"variance": 0.013178, "average": 0.950401, "min": 0.476418}, "location": {"width": 815, "top": 1238, "height": 36, "left": 229}, "words": "出现依西美坦相关的放射性标记物。在单次口饲剂量为1mg/kg的1C标记的依西美坦后24小时,大"}, {"probability": {"variance": 0.000842, "average": 0.98821, "min": 0.865626}, "location": {"width": 811, "top": 1265, "height": 31, "left": 230}, "words": "鼠乳汁和血浆中依西美及其代谢产物的浓度近似相等。尚不清楚依西美坦是否可泌入人乳汁中"}, {"probability": {"variance": 0.000526, "average": 0.990131, "min": 0.892571}, "location": {"width": 590, "top": 1293, "height": 28, "left": 232}, "words": "因为许多药物可以泌入人乳汁中,所以应防止哺乳期妇女不慎使用本品"}, {"probability": {"variance": 0.001127, "average": 0.984159, "min": 0.909106}, "location": {"width": 102, "top": 1344, "height": 22, "left": 241}, "words": "【儿童用药】"}, {"probability": {"variance": 0.009537, "average": 0.97426, "min": 0.481441}, "location": {"width": 516, "top": 1364, "height": 29, "left": 232}, "words": "尚未评估本品在儿童患者中的疗效和安全性。不推荐儿童使用"}, {"probability": {"variance": 0.031429, "average": 0.893345, "min": 0.58634}, "location": {"width": 82, "top": 1426, "height": 24, "left": 247}, "words": "老年用药"}, {"probability": {"variance": 0.017833, "average": 0.949753, "min": 0.366262}, "location": {"width": 495, "top": 1447, "height": 28, "left": 228}, "words": "在老年患者中用本品无特别注意事项。参见【用法用量】"}, {"probability": {"variance": 0.000481, "average": 0.987094, "min": 0.927487}, "location": {"width": 246, "top": 1507, "height": 28, "left": 250}, "words": "对于驾驶和机械操作的影响】"}, {"probability": {"variance": 0.000241, "average": 0.983046, "min": 0.957716}, "location": {"width": 125, "top": 1586, "height": 23, "left": 579}, "words": "8页,共16页"}], "language": 3}